4D Molecular Therapeutics Inc FDMT:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EST
42.34quote price arrow up+1.80 (+4.44%)
Volume
104,913
52 week range
35.01 - 55.11

...

Loading . . .

KEY STATS

  • Open40.02
  • Day High44.65
  • Day Low40.02
  • Prev Close40.54
  • 52 Week High55.11
  • 52 Week High Date02/11/21
  • 52 Week Low35.01
  • 52 Week Low Date01/05/21
  • Market Cap1.122B
  • Shares Out26.49M
  • 10 Day Average Volume0.14M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-9.38
  • P/E (TTM)-4.51
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-51.112M
  • ROE (MRQ)-
  • Revenue (MRQ)16.62M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-314.47%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest 4D Molecular Therapeutics Inc News

There is no recent news for this security.

Latest FDMT News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
4D Molecular Therapeutics, Inc. is a development stage gene therapy company. The Company is focused on the development of targeted therapies based on its adeno-associated viruses (AAV) vectors. It uses its Therapeutic Vector Evolution platform to customize its AAV vectors to target specific tissue types associated with the disease. The Company is focuses on three therapeutic areas: ophthalmology (intravitreal vector), cardiology (intravenous vector) and pulmonology (aerosol...
John Milligan Ph.D.
Chairman
David Kirn M.D.
Chief Executive Officer
Fred Kamal Ph.D.
Chief Operating Officer
August Moretti J.D.
Chief Financial Officer
Address
5858 Horton Street #455, Emeryville
Emeryville, CA
94608
United States